Progyny Inc at Barclays Global Healthcare Conference Transcript
Thank you, everyone, so much for coming. My name is Sarah James. I'm the emerging health care delivery model and Provider Analyst at Barclays, and I'm really thrilled to have with us here Progyny. It's our top pick and really has been mine since your IPO. And we have CFO, Mark Livingston with us today and also CEO, Peter Anevski.
Questions & Answers
And I think we're going to start off with some questions about the macro because I always find that's where the debate kind of starts with fertility insurance. You guys don't know. Progyny is one of the leading providers of fertility insurance in the U.S.
So how do you think about the TAM developing over the next 5 years? And then within that, what does the breakdown shift look like between people that can't get access and have no coverage versus employer-sponsored and self-pay?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |